MedPath

Autologous Regeneration of Tissue (ART) for Wound Healing

Not Applicable
Active, not recruiting
Conditions
Wound of Skin
Interventions
Device: Autologous Regeneration of Tissue (ART) device
Registration Number
NCT03796988
Lead Sponsor
University of Miami
Brief Summary

The purpose of this research study is to learn about a new device, Autologous Regeneration of Tissue (ART), for collecting skin grafts from participant's own skin.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adults from 18 to 90 years of age.
  • Patients that have a chronic wound in any area of the body defined as having been present for at least 30 days of duration.
  • Able and willing to give consent for the study.
Read More
Exclusion Criteria
  • Pregnant women (Urine hCG test will be performed at baseline on women of child bearing potential).
  • Adults unable to consent.
  • Prisoners.
  • Subjects requiring concurrent systemic antimicrobials during the study period for any infection.
  • Subjects with leg lesions and clinically significant and unreconstructed peripheral arterial disease.
  • Subjects who are receiving immunosuppressive agents, radiation therapy, or cytotoxic agents.
  • Subjects who require treatment for a primary or metastatic malignancy (other than squamous or basal cell carcinoma of the skin).
  • Subjects with other conditions considered by the investigator to be reasons for disqualification that may jeopardize subject safety or interfere with the objectives of the trial (e.g., acute illness or exacerbation of chronic illness, lack of motivation, history of poor compliance).
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention armAutologous Regeneration of Tissue (ART) deviceThe donor area will be anesthetized with injected local anesthesia, harvested with the ART device, and bandaged with an occlusive dressing. The skin harvested will be placed on the recipient wound area. The area will be bandaged will a non-stick silicone dressing (covered by appropriate primary and secondary dressings) and left intact for 1-7 days.
Primary Outcome Measures
NameTimeMethod
Change of pain on harvesting of skin at donor site.Baseline, Day 56

Pain assessed using a Pain Visual Analog Scale (VAS) with a score ranging from 0 (no pain) to 10 (worst possible pain)

Time to healing of donor sitesUp to Day 56

At each weekly visit, the donor site will be assessed for wound area in cm\^2

Secondary Outcome Measures
NameTimeMethod
Histologic evaluationUp to Day 56

As measured by tissue samples from biopsy

Wound healing of recipient siteUp to Day 56

At each weekly visit, the recipient area will be assessed for healing area percentage

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath